Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Market Cap	10.95B
Revenue (ttm)	2.82B
Net Income (ttm)	409.03M
Shares Out	66.89M
EPS (ttm)	6.07
PE Ratio	26.99
Forward PE	n/a
Dividend	2.50 (1.51%)
Ex-Dividend Date	Sep 12, 2025

Volume	120,353
Average Volume	49,463
Open	169.99
Previous Close	165.27
Day's Range	162.05 - 173.12
52-Week Range	155.00 - 301.65
Beta	-0.34
RSI	23.02
Earnings Date	Jan 21, 2026

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 1,399
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JAGSNPHARM

Financial Performance

In 2024, Jagsonpal Pharmaceuticals's revenue was 2.69 billion, an increase of 28.76% compared to the previous year's 2.09 billion. Earnings were 553.61 million, an increase of 146.45%.